Mirae Asset Global Investments Co. Ltd. Makes New Investment in iShares Biotechnology ETF $IBB

Mirae Asset Global Investments Co. Ltd. acquired a new position in iShares Biotechnology ETF (NASDAQ:IBB) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 28,691 shares of the financial services provider’s stock, valued at approximately $6,040,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Kaydan Wealth Management Inc. grew its stake in iShares Biotechnology ETF by 3.9% in the 3rd quarter. Kaydan Wealth Management Inc. now owns 1,363 shares of the financial services provider’s stock valued at $287,000 after purchasing an additional 51 shares during the period. Carter Financial Group INC. increased its position in shares of iShares Biotechnology ETF by 2.2% during the 2nd quarter. Carter Financial Group INC. now owns 2,423 shares of the financial services provider’s stock valued at $461,000 after purchasing an additional 53 shares during the last quarter. Parallel Advisors LLC raised its stake in shares of iShares Biotechnology ETF by 8.8% during the 1st quarter. Parallel Advisors LLC now owns 744 shares of the financial services provider’s stock worth $126,000 after purchasing an additional 60 shares during the period. Apollon Wealth Management LLC raised its stake in shares of iShares Biotechnology ETF by 0.7% during the 3rd quarter. Apollon Wealth Management LLC now owns 8,178 shares of the financial services provider’s stock worth $1,722,000 after purchasing an additional 60 shares during the period. Finally, Global Assets Advisory LLC raised its stake in shares of iShares Biotechnology ETF by 3.1% during the 3rd quarter. Global Assets Advisory LLC now owns 2,082 shares of the financial services provider’s stock worth $432,000 after purchasing an additional 62 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $210.18 on Friday. The company’s 50-day moving average is $208.49 and its 200 day moving average is $185.69. iShares Biotechnology ETF has a fifty-two week low of $154.98 and a fifty-two week high of $222.29.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 18th. Investors of record on Tuesday, September 15th were issued a dividend of $0.0112 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.0%. This is a drop from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. The ex-dividend date was Tuesday, September 15th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.